100% French Stocks – February 16, 2026

CAC 40 PREOPEN: 8,329 points (+0.26%)

Key Stocks of the Day

Sanofi (SAN)

The lab announces that its Beyfortus RSV vaccine significantly reduces childhood hospitalizations.
A very positive signal for the vaccine division and 2026 commercial visibility. Potential upside impact at the open.

EssilorLuxottica (EL)

The group has increased its stake in Nikon Corp to 15.41%.
Strategic strengthening in optics and precision technologies. Long-term confidence signal.

Peugeot Invest (PEUG)

Sale of remaining stake in LISI for €116M.
Cash-generating transaction, likely to fund new investments.

Crédit Agricole (ACA)

Fine of €7.55M imposed by the ECB for non-compliance with certain climate regulations.
Financial impact limited, but increased ESG pressure.

Valneva (VLA)

Delay in the UK recommendation for its chikungunya vaccine.
Poor short-term visibility, expected volatility.

Nicox (COX)

Positive written feedback from the FDA after pre-NDA meeting for NCX 470.
The application is considered broadly acceptable for planned summer 2026 submission.
Potential financial milestone with Kowa. Very favorable signal.

ABL Diagnostics (ABLD)

Sale of 128,026 shares to Alumni Capital as part of an agreement signed in October 2025.
Technical transaction with no immediate operational impact, but free float to watch.

Results Calendar

(Few major French releases expected today – session dominated by corporate flows and recommendations.)

Analyst Recommendations (France Only)

Recommendation Changes

Upgrades

Orange (ORA) → Berenberg maintains Buy, target raised from €15 to €18.
Constructive view on cash flow and financial discipline.

Neutral

Gecina (GFC) → Bernstein maintains Outperform, target cut from €108 to €95.
Prudent adjustment in listed real estate.

Unibail-Rodamco-Westfield (URW) → Bernstein maintains Outperform, target lifted from €115 to €119.
Support for premium assets and deleveraging momentum.